MT1G and neoplasm: Moreover, our subcutaneous tumor experiment in immunodeficiency mice revealed that MT1G knockdown markedly inhibits ccRCC growth, with a noticeable decrease in the number of lipid droplets in tumors formed by MT1G knockdown cells compared to the control group (Supplementary Fig. 6f–h).